Homerobotics

robotics

biotech

FDA Orphan Drug Designation and Rare Pediatric Disease Designation for sarcoma drug

Jim Cornall - October 6, 2026

biotech

Confidence boost for AI virtual cells for novel target discovery

Jim Cornall - October 6, 2026

biotech

Anti-fibrotic drug could be repurposed to control cell communication

Jim Cornall - October 6, 2026

biotech

Positive data from oral therapy designed to improve muscle function and body composition

Jim Cornall - October 5, 2026

robotics

Opentrons announces robotics education initiative

Jim Cornall - March 13, 2024

automation

IFAM – a growing important event on the European technology calendar

Jim Cornall - March 11, 2024

automation

Challenges and opportunities for European industry in 2024

Jim Cornall - January 11, 2024

robotics

China dominates growth of global industrial robots

Jim Cornall - December 8, 2023

robotics

Remote-controlled robotics for surgery applications – What potential do 6G and AI hold?

Jim Cornall - November 1, 2023

robotics

From Europe to Asia: trends, supply chains and used industrial robots

Jim Cornall - October 25, 2023

energy

Accelerating battery research with robots

Jim Cornall - September 14, 2023

robotics

Collaboration on wearable robotics

Jim Cornall - August 9, 2023

123 Page 2 of 3

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

FDA Orphan Drug Designation and Rare Pediatric Disease Designation for sarcoma drug

Jim Cornall - October 6, 2026 0

UTR Therapeutics Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to 3′UTRMYCN M1-14 (UTRxMYCN M1-14)...

Confidence boost for AI virtual cells for novel target discovery

biotech Jim Cornall - October 6, 2026 0

Anti-fibrotic drug could be repurposed to control cell communication

biotech Jim Cornall - October 6, 2026 0

Positive data from oral therapy designed to improve muscle function and body composition

biotech Jim Cornall - October 5, 2026 0

Pneumonia can reveal undiagnosed blood cancer

biotech Jim Cornall - October 5, 2026 0